Project R-16979
Title
StemServe: from academic to commercial platform (Research)
Abstract
A proprietary collection of human-derived dental pulp stem cells (DPSCs) has been collected and
developed from wisdom teeth. These cells can be differentiated in a number of cell types to be used in drug
testing. DPSC-derived Schwann cells linked to Charcot-Marie-Tooth disease are the first use case. In this
project, several experiments are being performed to further validate the technology to strengthen the business
case, industry-readiness, and intellectual property position.
Period of project
24 September 2026 - 31 December 2027